These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 2429844
1. Antiarrhythmic efficacy of propafenone: evaluation of effective plasma levels following single and multiple doses. Frabetti L, Marchesini B, Capucci A, Cavallini C, Gubelli S, Ambrosioni E, Magnani B. Eur J Clin Pharmacol; 1986; 30(6):665-71. PubMed ID: 2429844 [Abstract] [Full Text] [Related]
2. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone]. Geibel A, Zehender M, Hohnloser S, Landsrath C, Meinertz T, Just H. Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720 [Abstract] [Full Text] [Related]
3. [Propafenone: evaluation of antiarrhythmic efficacy in hyperkinetic ventricular arrhythmia using acute oral test]. Boriani G, Capucci A, Balducelli M, Frabetti L, Marchesini B, Tomasi L, Ambrosioni E, Magnani B. Cardiologia; 1988 Nov; 33(11):1061-7. PubMed ID: 2475253 [No Abstract] [Full Text] [Related]
4. LG 6-101 and LG 6-102, two new propafenone-related antiarrhythmic agents with good oral activity in rats. Wascher TC, Dittrich P, Kukovetz WR. Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):473-7. PubMed ID: 1620247 [Abstract] [Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of propafenone during acute and chronic administration. Giani P, Landolina M, Giudici V, Bianchini C, Ferrario G, Marchi S, Riva E, Latini R. Eur J Clin Pharmacol; 1988 Apr; 34(2):187-94. PubMed ID: 3383990 [Abstract] [Full Text] [Related]
6. [Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole]. Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Huguet R, Wajman A. Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1495-505. PubMed ID: 2432845 [Abstract] [Full Text] [Related]
7. [Evaluation of the rate for reaching steady state during oral propafenone therapy in patients with ventricular arrhythmias]. Dabrowski R, Skrabucha B, Kunicki PK, Kowalik I, Skorykow-Sapińska A, Sitkiewicz D, Sadowski Z. Pol Arch Med Wewn; 1998 Apr; 99(4):323-30. PubMed ID: 9760820 [Abstract] [Full Text] [Related]
8. [Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)]. Dobrotvorskaia TE, Koroleva ON, Gordina OV, Marakanova AV. Klin Med (Mosk); 1996 Apr; 74(3):51-3. PubMed ID: 8926706 [No Abstract] [Full Text] [Related]
9. [Treatment of chronic ventricular extrasystole by propafenone (600 mg/d) in 2 or 3 daily doses]. Lardoux H, Valère PE, Djiane P, Maarek-Charbit M. Ann Cardiol Angeiol (Paris); 1993 May; 42(5):281-8. PubMed ID: 7690219 [Abstract] [Full Text] [Related]
10. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)]. Klempt HW, Nayebagha A, Fabry E. Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562 [Abstract] [Full Text] [Related]
11. Clinical pharmacology of propafenone. Connolly SJ, Kates RE, Lebsack CS, Harrison DC, Winkle RA. Circulation; 1983 Sep; 68(3):589-96. PubMed ID: 6872170 [Abstract] [Full Text] [Related]
12. Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment. Boriani G, Martignani C, Biffi M, Capucci A, Branzi A. Drugs; 2002 Sep; 62(3):415-23. PubMed ID: 11827557 [Abstract] [Full Text] [Related]
13. [The evaluation of the antiarrhythmic activity of L-carnitine and propafenone in ischemic cardiopathy]. Palazzuoli V, Mondillo S, Faglia S, D'Aprile N, Camporeale A, Gennari C. Clin Ter; 1993 Feb; 142(2):155-9. PubMed ID: 7682488 [Abstract] [Full Text] [Related]
15. Enhanced antiarrhythmic efficacy of propafenone when used in combination with procainamide or quinidine. Klein RC, Huang SK, Marcus FI, Horwitz L, Fenster PE, Rushforth N, Kirsten EB. Am Heart J; 1987 Sep; 114(3):551-8. PubMed ID: 3630896 [Abstract] [Full Text] [Related]
16. Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine. Lau CP, Chow MS, Tse HF, Tang MO, Fan C. Am J Cardiol; 2000 Dec 15; 86(12):1327-32. PubMed ID: 11113407 [Abstract] [Full Text] [Related]
17. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment]. Garimoldi M, Sghirinzetti M, Pirastu A, Cappiello E, Sala R, Terranova P. G Ital Cardiol; 1986 Apr 15; 16(4):328-32. PubMed ID: 2427383 [Abstract] [Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group. Zoble RG, Kirsten EB, Brewington J. Clin Pharmacol Ther; 1989 May 15; 45(5):535-41. PubMed ID: 2721109 [Abstract] [Full Text] [Related]
19. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms]. Mastropasqua F, Totaro P, Massari F, Pitzalis MV, Rizzon P. Cardiologia; 1998 Jun 15; 43(6):617-23. PubMed ID: 9675961 [Abstract] [Full Text] [Related]
20. Atrial flutter termination by overdrive transesophageal pacing and the facilitating effect of oral propafenone. Doni F, Della Bella P, Kheir A, Manfredi M, Piemonti C, Staffiere E, Rimondini A, Fiorentini C. Am J Cardiol; 1995 Dec 15; 76(17):1243-6. PubMed ID: 7503004 [Abstract] [Full Text] [Related] Page: [Next] [New Search]